An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab

This study has been completed.

Sponsor:

Collaborator:

Bayer

Information provided by (Responsible Party):

Sanofi ( Genzyme, a Sanofi Company )

ClinicalTrials.gov Identifier:

NCT00930553

First received: June 26, 2009

Last updated: March 11, 2016

Last verified: March 2016

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	February 2016
Primary Completion Date:	February 2016 (Final data collection date for primary outcome measure)